Clinical Trials in Minneapolis

Showing 8861-8880 of 14,456 trials

Ketamine in Adolescents With Treatment-Resistant Depression

NCT02078817

This study will test the use of ketamine for treatment of depression in adolescents that have not responded to other treatments. We will also examine neurobiological mechanisms of treatment.

Major Depressive Disorder

University of Minnesota14 participantsStarted Sep 2014

Minneapolis, Minnesota, United States

COMPLETED8.7 miles

Severe ARDS: Generating Evidence

NCT03021824

An assessment of early management of moderate-severe ARDS in the United States, including ventilator management and use of rescue therapy.

Acute Respiratory Distress SyndromeAcute Respiratory Failure With HypoxiaAcute Respiratory Failure

Montefiore Medical Center2,400 participantsStarted Oct 2016

Tucson, Arizona, United States • Los Angeles, California, United States • Los Angeles, California, United States +25 more locations

Ketamine in Adolescents With Treatment-Resistant Depression

Severe ARDS: Generating Evidence

Find Trials by Condition in Minneapolis

Catheter Ablation Versus Amiodarone for Shock Prophylaxis in Defibrillator Patients With Ventricular Tachycardia

Endotracheal Intubation Among the Critically Ill: HEMAIR Pilot Study

A Phase 2 Study of Viagenpumatucel-L (HS-110) in Patients With Non-Small Cell Lung Cancer

A Study to Evaluate the Safety and Efficacy of JNJ-64565111 in Non-diabetic Severely Obese Participants

Fludarabine Phosphate, Cyclophosphamide, Total-Body Irradiation, and Donor Bone Marrow Transplant Followed by Donor Natural Killer Cell Therapy, Mycophenolate Mofetil, and Tacrolimus in Treating Patients With Hematologic Cancer

Dasotraline Pediatric Extension Study

Evaluation of VX-659/TEZ/IVA in Cystic Fibrosis Subjects 6 Through 11 Years of Age

Topical Raplixa for Surgical Bleeding in Children

A Study to Evaluate a Potassium Normalization Treatment Regimen Including Sodium Zirconium Cyclosilicate (ZS) Among Patients With S-K ≥5.8

A Safety and Pharmacology Study of Atezolizumab (MPDL3280A) Administered With Obinutuzumab or Tazemetostat in Participants With Relapsed/Refractory Follicular Lymphoma and Diffuse Large B-cell Lymphoma

Vitamin D to Improve Outcomes by Leveraging Early Treatment

Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Boostrix™ Vaccine in Pregnant Women

Frozen Red Blood Cell Transfusions in Trauma Patients

TiLE (Time Lapse Eeva) Clinical Trial

ExAblate (MRgFUS) Treatment of Metastatic Bone Tumors for the Palliation of Pain

Tacrolimus and Mycophenolate Mofetil in Preventing Graft-Versus-Host Disease in Patients Who Have Undergone Total-Body Irradiation With or Without Fludarabine Phosphate Followed by Donor Peripheral Blood Stem Cell Transplant for Hematologic Cancer

Autologous Stem Cell Transplant Followed by Donor Stem Cell Transplant in Treating Patients With Relapsed or Refractory Lymphoma

Donor Lymphocyte Infusion in Treating Patients With Persistent, Relapsed, or Progressing Cancer After Donor Hematopoietic Cell Transplant